+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Congenital Adrenal Hyperplasia Treatment Market by Type (Classic, Non-Classic), Treatments (Corticosteroid, Glucocorticoids, Hormone Replacement Therapy), End-User - Forecast 2024-2030- Product Image
Global Congenital Adrenal Hyperplasia Treatment Market by Type (Classic, Non-Classic), Treatments (Corticosteroid, Glucocorticoids, Hormone Replacement Therapy), End-User - Forecast 2024-2030- Product Image
Sale

Global Congenital Adrenal Hyperplasia Treatment Market by Type (Classic, Non-Classic), Treatments (Corticosteroid, Glucocorticoids, Hormone Replacement Therapy), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5968099
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Congenital Adrenal Hyperplasia Treatment Market size was estimated at USD 384.98 million in 2023, USD 405.57 million in 2024, and is expected to grow at a CAGR of 5.47% to reach USD 558.96 million by 2030.

Congenital Adrenal Hyperplasia (CAH) treatment primarily involves hormone replacement therapy to compensate for the hormones that the adrenal glands fail to produce adequately. The most common form of treatment uses glucocorticoids to reduce androgen production and manage symptoms effectively. For certain cases, mineralocorticoids are also prescribed to regulate sodium retention and potassium excretion. In some instances, surgical procedures may be necessary to correct anatomical abnormalities associated with CAH. Early diagnosis and tailored treatment are essential to manage the condition effectively, prevent complications, and improve the quality of life for individuals with CAH.

Growing awareness and improved newborn screening programs globally have increased diagnosis rates, directly impacting the demand for effective CAH treatments. However, long-term use of corticosteroids and other hormonal treatments can have significant side effects, which may deter compliance with treatment regimes. Developing comprehensive care models that integrate diagnostics, treatment, patient education, and follow-up could improve patient outcomes and expand market reach. In addition, an exploration into gene editing and therapy presents a significant opportunity to address CAH at its genetic root, potentially reducing dependency on lifelong hormone therapies.

Regional Insights

In the Americas, Particularly in the United States and Canada, advanced healthcare infrastructure and high awareness about genetic disorders drive the treatment market for congenital adrenal hyperplasia (CAH). The region sees significant research activities and clinical trials aiming to develop new treatments and manage CAH more effectively. The U.S. Food and Drug Administration (FDA) regulates treatments and ensures safety and efficacy. Investments in healthcare and the availability of reimbursement mechanisms help address CAH patients' needs effectively. On the other hand, countries within the EMEA show high heterogeneity in CAH due to differences in healthcare policies and economic capabilities.

EU countries generally have robust healthcare systems with mandatory newborn screening for CAH, promoting early diagnosis and treatment adherence. Recent EU patents suggest a focus on innovative steroid treatments and genetic therapies. Moreover, in the Asia Pacific region, the market for CAH treatment is observing gradual growth, driven primarily by increasing awareness and improved diagnostic methods. CAH is a genetic disorder affecting adrenal glands and can lead to various health complications if not treated appropriately. Countries in this region are progressively enhancing their healthcare infrastructures, facilitating better access to treatments and supporting market growth.

Market Trends by Segment

  • Type: Preference for classic CAH treatment due to facilitate normal growth and development in newborns
  • End-User: Widening availability of CAH treatment thorugh varied healthcare institution to cater urgent and comprehensive conditions

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

FDA Accelerates Approval Process for New Oral Drug Treating Congenital Adrenal Hyperplasia

The U.S. Food and Drug Administration (FDA) awarded breakthrough therapy designation to a novel oral medication designed to manage congenital adrenal hyperplasia (CAH), a decision poised to streamline the drug’s development and review processes. This promising treatment option, distinguished by its ease of use compared to traditional therapies, specifically targets the underlying genetic conditions of CAH, offering potentially improved patient outcomes. With separate formulations under evaluation for pediatric and adult patients, the drug aims to address the needs of various age groups, enhancing the standard of care for individuals afflicted with this chronic condition.

BridgeBio Pharma and National Resilience Forge Partnership to Enhance Gene Therapy Innovations

BridgeBio Pharma Inc. and National Resilience, Inc. have entered into a significant partnership to develop and manufacture innovative gene therapies, focusing primarily on rare diseases such as Congenital Adrenal Hyperplasia. This strategic alliance aims to utilize Resilience's advanced manufacturing technologies and BridgeBio's therapeutic development strategies to accelerate the production of new treatments. This partnership reflects a shared commitment to transforming scientific discoveries into accessible medical treatments, potentially improving patients' lives with limited therapeutic options.

Key Company Profiles

The report delves into recent significant developments in the Congenital Adrenal Hyperplasia Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Adrenas Therapeutics, Inc. by, Amgen Inc., BioMarin Pharmaceutical Inc., BridgeBio Pharma, EffRx Pharmaceuticals, GSK PLC, Johnson and Johnson Services, Inc., Merck & Co., Inc., Millendo Therapeutics, Inc., Neurocrine Biosciences, Inc., Novartis AG, Pfizer Inc., Sanofi SA, Spruce Bioscience, Thermo Fisher Scientific Inc., and Zydus Group.

This research report offers invaluable insights into various crucial aspects of the Congenital Adrenal Hyperplasia Treatment Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing awareness related to genetic disorders and improved newborn screening programs globally
5.1.1.2. Favorable government initiatives and reimbursement policies for CAH treatment
5.1.2. Restraints
5.1.2.1. Strict regulations regarding drug approvals
5.1.3. Opportunities
5.1.3.1. Innovation in drug formulation and delivery systems for CAH
5.1.3.2. Advancements in gene editing and hormone therapies
5.1.4. Challenges
5.1.4.1. Significant side effects associated with the CAH drugs
5.2. Market Segmentation Analysis
5.2.1. Type: Preference for classic CAH treatment due to facilitate normal growth and development in newborns
5.2.2. End-User: Widening availability of CAH treatment thorugh varied healthcare institution to cater urgent and comprehensive conditions
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Congenital Adrenal Hyperplasia Treatment Market, by Type
6.1. Introduction
6.2. Classic
6.3. Non-Classic
7. Congenital Adrenal Hyperplasia Treatment Market, by Treatments
7.1. Introduction
7.2. Corticosteroid
7.3. Glucocorticoids
7.4. Hormone Replacement Therapy
7.5. Medication
7.6. Salt Supplements
7.7. Surgery
8. Congenital Adrenal Hyperplasia Treatment Market, by End-User
8.1. Introduction
8.2. Hospitals
8.3. Pharmacies
8.4. Specialty Clinics
9. Americas Congenital Adrenal Hyperplasia Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Congenital Adrenal Hyperplasia Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Congenital Adrenal Hyperplasia Treatment Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. FDA Accelerates Approval Process for New Oral Drug Treating Congenital Adrenal Hyperplasia
12.3.2. BridgeBio Pharma and National Resilience Forge Partnership to Enhance Gene Therapy Innovations
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET DYNAMICS
FIGURE 7. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY CLASSIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY CLASSIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY NON-CLASSIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY NON-CLASSIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY GLUCOCORTICOIDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY GLUCOCORTICOIDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY SALT SUPPLEMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY SALT SUPPLEMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 43. ARGENTINA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 44. ARGENTINA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 45. ARGENTINA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 46. ARGENTINA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 49. BRAZIL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 50. BRAZIL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 51. BRAZIL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 52. BRAZIL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 55. CANADA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 56. CANADA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 57. CANADA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 58. CANADA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 59. CANADA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. CANADA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. MEXICO CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 62. MEXICO CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 63. MEXICO CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 64. MEXICO CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 65. MEXICO CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 66. MEXICO CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 69. UNITED STATES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 70. UNITED STATES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 71. UNITED STATES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 72. UNITED STATES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 73. UNITED STATES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 74. UNITED STATES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 78. ASIA-PACIFIC CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 80. ASIA-PACIFIC CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 82. ASIA-PACIFIC CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 83. AUSTRALIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 84. AUSTRALIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 85. AUSTRALIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 86. AUSTRALIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 87. AUSTRALIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 88. AUSTRALIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 89. CHINA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 90. CHINA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 91. CHINA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 92. CHINA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 93. CHINA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 94. CHINA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 95. INDIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 96. INDIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 97. INDIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 98. INDIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 99. INDIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 100. INDIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 101. INDONESIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 102. INDONESIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 103. INDONESIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 104. INDONESIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 105. INDONESIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 106. INDONESIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 107. JAPAN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 108. JAPAN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 109. JAPAN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 110. JAPAN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 111. JAPAN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 112. JAPAN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 113. MALAYSIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 114. MALAYSIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 115. MALAYSIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 116. MALAYSIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 117. MALAYSIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 118. MALAYSIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 119. PHILIPPINES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 120. PHILIPPINES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 121. PHILIPPINES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 122. PHILIPPINES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 123. PHILIPPINES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 124. PHILIPPINES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 125. SINGAPORE CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 126. SINGAPORE CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 127. SINGAPORE CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 128. SINGAPORE CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 129. SINGAPORE CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. SINGAPORE CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. SOUTH KOREA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 132. SOUTH KOREA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 133. SOUTH KOREA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 134. SOUTH KOREA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 135. SOUTH KOREA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 136. SOUTH KOREA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 137. TAIWAN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 138. TAIWAN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 139. TAIWAN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 140. TAIWAN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 141. TAIWAN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 142. TAIWAN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 143. THAILAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 144. THAILAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 145. THAILAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 146. THAILAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 147. THAILAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 148. THAILAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 149. VIETNAM CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 150. VIETNAM CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 151. VIETNAM CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 152. VIETNAM CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 153. VIETNAM CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 154. VIETNAM CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 163. DENMARK CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 164. DENMARK CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 165. DENMARK CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 166. DENMARK CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 167. DENMARK CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 168. DENMARK CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 169. EGYPT CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 170. EGYPT CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 171. EGYPT CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 172. EGYPT CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 173. EGYPT CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 174. EGYPT CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 175. FINLAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 176. FINLAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 177. FINLAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 178. FINLAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 179. FINLAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 180. FINLAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 181. FRANCE CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 182. FRANCE CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 183. FRANCE CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 184. FRANCE CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 185. FRANCE CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 186. FRANCE CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 187. GERMANY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 188. GERMANY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 189. GERMANY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 190. GERMANY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 191. GERMANY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 192. GERMANY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 193. ISRAEL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 194. ISRAEL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 195. ISRAEL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 196. ISRAEL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 197. ISRAEL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 198. ISRAEL CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 199. ITALY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 200. ITALY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 201. ITALY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 202. ITALY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 203. ITALY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 204. ITALY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 205. NETHERLANDS CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 206. NETHERLANDS CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 207. NETHERLANDS CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 208. NETHERLANDS CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 209. NETHERLANDS CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 210. NETHERLANDS CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 211. NIGERIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 212. NIGERIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 213. NIGERIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 214. NIGERIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 215. NIGERIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 216. NIGERIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 217. NORWAY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 218. NORWAY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 219. NORWAY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 220. NORWAY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 221. NORWAY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 222. NORWAY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 223. POLAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 224. POLAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 225. POLAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 226. POLAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 227. POLAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 228. POLAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 229. QATAR CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 230. QATAR CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 231. QATAR CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 232. QATAR CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 233. QATAR CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 234. QATAR CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 235. RUSSIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 236. RUSSIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 237. RUSSIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 238. RUSSIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 239. RUSSIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 240. RUSSIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 242. SAUDI ARABIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 244. SAUDI ARABIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 246. SAUDI ARABIA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 248. SOUTH AFRICA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 250. SOUTH AFRICA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 252. SOUTH AFRICA CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 253. SPAIN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 254. SPAIN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 255. SPAIN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 256. SPAIN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 257. SPAIN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 258. SPAIN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 259. SWEDEN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 260. SWEDEN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 261. SWEDEN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 262. SWEDEN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 263. SWEDEN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 264. SWEDEN CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 265. SWITZERLAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 266. SWITZERLAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 267. SWITZERLAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 268. SWITZERLAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 269. SWITZERLAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 270. SWITZERLAND CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 271. TURKEY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 272. TURKEY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 273. TURKEY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 274. TURKEY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 275. TURKEY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 276. TURKEY CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 284. UNITED KINGDOM CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 286. UNITED KINGDOM CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 288. UNITED KINGDOM CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 289. CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 290. CONGENITAL ADRENAL HYPERPLASIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • AbbVie Inc.
  • Adrenas Therapeutics, Inc. by
  • Amgen Inc.
  • BioMarin Pharmaceutical Inc.
  • BridgeBio Pharma
  • EffRx Pharmaceuticals
  • GSK PLC
  • Johnson and Johnson Services, Inc.
  • Merck & Co., Inc.
  • Millendo Therapeutics, Inc.
  • Neurocrine Biosciences, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Spruce Bioscience
  • Thermo Fisher Scientific Inc.
  • Zydus Group

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 405.57 Million
Forecasted Market Value ( USD ) by 2030 $ 558.96 Million
Compound Annual Growth Rate5.4%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Pediatric Growth Hormone Deficiency Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F - Product Image

Pediatric Growth Hormone Deficiency Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

  • Report
  • 175 Pages
  • Global
From
Compounded Bioidentical Hormone Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Compounded Bioidentical Hormone Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 220 Pages
  • Global
Pediatric Growth Hormone Deficiency - Pipeline Insight, 2024 - Product Image

Pediatric Growth Hormone Deficiency - Pipeline Insight, 2024

  • Clinical Trials
  • 40 Pages
  • Global
From
Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 190 Pages
  • Global
From
Global Acromegaly Treatment Market by Disease Type (Ectopic Acromegaly, Pseudo Acromegaly), Drug Class (Bromocriptine Mesylate (Parlodel), Dopamine Agonists, Growth Hormone Receptor Antagonist), Distribution Channel, End-User - Forecast 2024-2030 - Product Image

Global Acromegaly Treatment Market by Disease Type (Ectopic Acromegaly, Pseudo Acromegaly), Drug Class (Bromocriptine Mesylate (Parlodel), Dopamine Agonists, Growth Hormone Receptor Antagonist), Distribution Channel, End-User - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From

About the Congenital Adrenal Hyperplasia Drug Market

Congenital Adrenal Hyperplasia (CAH) is a group of inherited disorders that affect the adrenal glands. It is caused by a deficiency in the enzymes that produce cortisol and aldosterone, hormones that regulate the body's metabolism and response to stress. Treatment for CAH typically involves hormone replacement therapy, which can be administered orally or through injections. Endocrine and Metabolic Disorders Drugs are used to treat CAH and other endocrine and metabolic disorders. These drugs are designed to restore the body's balance of hormones and to reduce the symptoms of the disorder. The Congenital Adrenal Hyperplasia Drug market is a subset of the larger Endocrine and Metabolic Disorders Drugs market. It is composed of drugs that are specifically designed to treat CAH and its associated symptoms. These drugs are used to restore the body's balance of hormones and to reduce the symptoms of the disorder. Some companies in the Congenital Adrenal Hyperplasia Drug market include Novartis, Merck, Pfizer, Sanofi, and GlaxoSmithKline. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.